These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18563509)

  • 21. Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.
    Donohoe CL; Sayana MK; Thakral R; Niall DM
    Ir J Med Sci; 2011 Sep; 180(3):627-32. PubMed ID: 21286842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient.
    Galanis T; Kraft WK; Merli GJ
    Adv Surg; 2011; 45():361-90. PubMed ID: 21954699
    [No Abstract]   [Full Text] [Related]  

  • 23. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
    Fisher WD; Eriksson BI; Bauer KA; Borris L; Dahl OE; Gent M; Haas S; Homering M; Huisman MV; Kakkar AK; Kälebo P; Kwong LM; Misselwitz F; Turpie AG
    Thromb Haemost; 2007 Jun; 97(6):931-7. PubMed ID: 17549294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
    Heit JA; Colwell CW; Francis CW; Ginsberg JS; Berkowitz SD; Whipple J; Peters G;
    Arch Intern Med; 2001 Oct; 161(18):2215-21. PubMed ID: 11575978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.
    Eriksson BI; Agnelli G; Cohen AT; Dahl OE; Mouret P; Rosencher N; Eskilson C; Nylander I; Frison L; Ogren M;
    Thromb Haemost; 2003 Feb; 89(2):288-96. PubMed ID: 12574809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
    Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
    Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership.
    Mesko JW; Brand RA; Iorio R; Gradisar I; Heekin R; Leighton R; Thornberry R
    J Arthroplasty; 2001 Sep; 16(6):679-88. PubMed ID: 11547365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of venous thromboembolism.
    Geerts W; Ray JG; Colwell CW; Bergqvist D; Pineo GF; Lassen MR; Heit JA
    Chest; 2005 Nov; 128(5):3775-6. PubMed ID: 16304350
    [No Abstract]   [Full Text] [Related]  

  • 29. A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor.
    Gomez D; Razmjou H; Donovan A; Bansal VB; Gollish JD; Murnaghan JJ
    J Arthroplasty; 2017 Mar; 32(3):958-964. PubMed ID: 27843040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis.
    Chahal GS; Saithna A; Brewster M; Gilbody J; Lever S; Khan WS; Foguet P
    Ortop Traumatol Rehabil; 2013; 15(2):125-9. PubMed ID: 23652532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
    Lotke PA; Callaghan JJ; Dorr LD; Engh GH; Hanssen AD; Healy WL; Lachiewicz PF; Lonner JH; Nelson C; Ranawat CS; Ritter MA; Salvati EA; Sculco TP; Thornhill TS
    J Bone Joint Surg Am; 2006 May; 88(5):1163; author reply 1163-5. PubMed ID: 16651602
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances in DVT prophylaxis and management in major orthopaedic surgery.
    Hardwick ME; Colwell CW
    Surg Technol Int; 2004; 12():265-8. PubMed ID: 15455336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism debate in joint arthroplasty.
    Lieberman JR; Barnes CL; Lachiewicz PF; Hanssen AD; Clarke HD; Pellegrini VD
    J Bone Joint Surg Am; 2009 Aug; 91 Suppl 5():29-32. PubMed ID: 19648620
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral direct factor Xa inhibitor gets FDA's OK.
    Thompson CA
    Am J Health Syst Pharm; 2011 Aug; 68(16):1467. PubMed ID: 21817076
    [No Abstract]   [Full Text] [Related]  

  • 36. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
    Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
    Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin.
    Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H
    Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Benefit/risk ratio analysis from a possible anticoagulation of asymptomatic deep venous thrombosis in major orthopedic surgery].
    Barrellier MT; Samama CM
    J Mal Vasc; 2013 May; 38(3):178-84. PubMed ID: 23415379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep vein thrombosis prophylaxis.
    Weber KL; Zuckerman JD; Watters WC; Turkelson CM
    Chest; 2009 Dec; 136(6):1699-1700. PubMed ID: 19995776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.